IQVIA Holdings Inc. (IQV)

Price$186.82

Value ScoreC

Growth ScoreB

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-32.01%

Price vs S&P 500 (4W)10.52%

VGM Score57.26

Market Capitalization$30.41B

P/E Ratio (Annual)22.36x

All Metrics

P/CF (Annual)11.46x

Book Value / Share (Quarterly)$37.27

P/TBV (Annual)24.91x

Revenue Growth (3Y)4.21%

Cash Flow / Share (Quarterly)$12.68

Price vs S&P 500 (YTD)-30.10%

Gross Margin (TTM)32.99%

Net Profit Margin (TTM)8.33%

EPS (TTM)$8.07

10-Day Avg Trading Volume1.89M

EPS Excl Extra (TTM)$8.07

Revenue Growth (5Y)7.50%

EPS (Annual)$7.84

ROI (Annual)6.06%

Gross Margin (Annual)33.29%

Net Profit Margin (5Y Avg)8.17%

Cash / Share (Quarterly)$12.60

P/E Basic Excl Extra (TTM)21.96x

Revenue Growth QoQ (YoY)8.41%

EPS Growth (5Y)40.52%

P/E Normalized (Annual)22.36x

ROA (Last FY)4.54%

Revenue Growth TTM (YoY)7.32%

EBITD / Share (TTM)$19.61

ROE (5Y Avg)20.13%

Operating Margin (TTM)13.22%

Cash Flow / Share (Annual)$12.09

P/B Ratio4.89x

P/B Ratio (Quarterly)4.60x

Net Income / Employee (Annual)$14,600

EV / Revenue (TTM)2.66x

Net Interest Coverage (TTM)3.33x

ROA (TTM)4.74%

EPS Growth QoQ (YoY)14.97%

EV / EBITDA (TTM)13.16x

EPS Incl Extra (Annual)$7.84

Current Ratio (Annual)0.75x

Quick Ratio (Quarterly)0.73x

3-Month Avg Trading Volume2.02M

52-Week Price Return29.21%

EV / Free Cash Flow (Annual)21.60x

P/E Incl Extra (TTM)21.96x

Revenue / Employee (TTM)$178,800

Tangible BV / Share (Quarterly)$8.50

P/S Ratio (Annual)1.86x

Asset Turnover (Annual)0.54x

52-Week High$247.05

Operating Margin (5Y Avg)12.62%

EPS Excl Extra (Annual)$7.84

CapEx CAGR (5Y)-0.43%

Tangible BV CAGR (5Y)14.12%

26-Week Price Return-16.07%

Quick Ratio (Annual)0.73x

13-Week Price Return6.78%

Total Debt / Equity (Annual)2.45x

Current Ratio (Quarterly)0.75x

Enterprise Value$44.30B

Revenue / Share Growth (5Y)10.04%

Asset Turnover (TTM)0.57x

Book Value / Share Growth (5Y)4.06%

Revenue / Employee (Annual)$175,400

Pretax Margin (Annual)9.75%

Cash / Share (Annual)$12.62

3-Month Return Std Dev44.34%

Gross Margin (5Y Avg)34.30%

Net Income / Employee (TTM)$14,900

EBITDA CAGR (5Y)10.61%

EBITDA Interim CAGR (5Y)4.58%

ROE (Last FY)20.91%

Net Interest Coverage (Annual)3.24x

EPS Basic Excl Extra (Annual)$7.84

P/FCF (TTM)14.37x

Receivables Turnover (TTM)5.03x

EV / Free Cash Flow (TTM)20.93x

Total Debt / Equity (Quarterly)2.55x

EPS Incl Extra (TTM)$8.07

Receivables Turnover (Annual)4.94x

ROI (TTM)6.39%

P/S Ratio (TTM)1.83x

Pretax Margin (5Y Avg)9.58%

Revenue / Share (Annual)$94.01

Tangible BV / Share (Annual)$9.09

Forward P/E14.69x

Free OCF CAGR (5Y)8.84%

Price vs S&P 500 (52W)1.00%

P/E Ratio (TTM)21.96x

EPS Growth TTM (YoY)9.98%

Year-to-Date Return-19.17%

5-Day Price Return8.52%

EPS Normalized (Annual)$7.84

ROA (5Y Avg)4.59%

Net Profit Margin (Annual)8.34%

Month-to-Date Return15.05%

Cash Flow / Share (TTM)$12.15

EBITD / Share (Annual)$19.14

EPS Growth (3Y)11.13%

Operating Margin (Annual)13.34%

LT Debt / Equity (Annual)2.13x

P/CF (TTM)11.25x

ROI (5Y Avg)6.14%

P/E Excl Extra (TTM)21.96x

LT Debt / Equity (Quarterly)2.25x

EPS Basic Excl Extra (TTM)$8.07

P/TBV (Quarterly)20.19x

P/B Ratio (Annual)5.90x

Pretax Margin (TTM)9.60%

Book Value / Share (Annual)$38.34

Price vs S&P 500 (13W)-2.97%

Net Margin Growth (5Y)27.66%

Beta1.22x

P/FCF (Annual)14.83x

Revenue / Share (TTM)$97.95

ROE (TTM)22.46%

52-Week Low$136.41

vGradeC

gGradeB

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 262.90est. 2.85

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.13

4.19

Industry Peers — R&D — Physical Sciences(15)

Symbol	Value Score	Growth Score	Momentum Score	Price
IQVIQVIA Holdings Inc.	C	B	B	$186.82
INCYIncyte Genomics Inc	C	A	B	$95.59
MEDPMedpace Holdings, Inc. Common Stock	D	A	B	$451.47
ICLRIcon Plc	C	C	B	$138.03
CRLCharles River Laboratories International, Inc.	D	D	B	$182.07
ABSIAbsci Corporation Common Stock	F	F	A	$6.52
NRCNRC Health Common Stock	D	D	B	$20.25
OABIOmniAb, Inc. Common Stock	D	C	A	$2.61
MXCTMaxCyte, Inc. Common Stock	C	D	C	$1.22
ONMDOneMedNet Corp Class A Common Stock	D	C	C	$0.78
NOTVInotiv, Inc. Common Stock	B	B	D	$0.31

About

IQVIA provides outsourced clinical trial services and healthcare data analytics to the global pharmaceutical and healthcare industries. The company operates through two segments: Research & Development, offering late-stage clinical trials to pharmaceutical, medical device, and diagnostic companies; and Technology & Analytics, delivering aggregated data and analytics solutions to pharmaceutical firms, healthcare providers, payers, and policymakers.